Although the FDA has approved TMS for depression, Aetna limits coverage to cases of treatment-resistant depression. If a PTSD patient also has major depression, they may still be eligible for TMS.
Although the FDA has approved TMS for depression, Blue Shield currently covers TMS treatment to treat depression only, not PTSD as a primary diagnosis. However, many PTSD patients still qualify because they also meet criteria for treatment-resistant depression.
Although the FDA has approved TMS for depression, Blue Cross currently covers TMS treatment to treat depression only, not PTSD as a primary diagnosis. Many PTSD patients still qualify if they have a coexisting diagnosis of major depression.
